Who Paid My Doc
Reekesh Patel
Pain Medicine Hawthorne, CA Medical Doctor
NPI 1043446982 CMS profile 819901
4477 W 118Th St Ste 501, Ste 501, Hawthorne, CA 90250
General payments
$17,583
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$230
Through program year 2025, Reekesh Patel of Hawthorne, CA is reported in the CMS Open Payments database as having received $17,583 across 594 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $230 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 92nd percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,117 | 89 | |
| 2024 | General | $2,419 | 86 | |
| 2023 | General | $4,339 | 136 | |
| 2022 | General | $3,763 | 143 | |
| 2021 | General | $1,697 | 57 | |
| 2020 | General | $1,712 | 59 | |
| 2019 | General | $1,535 | 24 |
Beside peers
- Reekesh Patel
- Pain Medicine median
- Middle half of Pain Medicine
- National median
In program year 2025, general payments to Reekesh Patel were reported at $2,117. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.
Show as a table
| Year | Reekesh Patel | Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,535 | $409 | $115–$1,311 | $163 |
| 2020 | $1,712 | $214 | $66–$666 | $114 |
| 2021 | $1,697 | $299 | $84–$899 | $132 |
| 2022 | $3,763 | $335 | $103–$1,149 | $149 |
| 2023 | $4,339 | $376 | $114–$1,228 | $160 |
| 2024 | $2,419 | $387 | $115–$1,173 | $164 |
| 2025 | $2,117 | $402 | $130–$1,173 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 17 billing codesPaid by Medicare
$199,710
Medicare patients
323
Services billed
2,564
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 54% | |
| COPD | 40% | |
| Ischemic heart disease | 33% | |
| Depression | 33% | |
| Heart failure | 30% | |
| Chronic kidney disease | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
594 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pain Medicine in California
Related records
Pain Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.